Dyspnea in idiopathic pulmonary fibrosis: A systematic review

Journal of Pain and Symptom Management

Volumn 43, Issue 4, 2012, Pages 771-782

  Ryerson, Christopher J ^a   Donesky, Doranne ^b   Pantilat, Steven Z ^a   Collard, Harold R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dyspnea; idiopathic pulmonary fibrosis; systematic review

Indexed keywords

ACETYLCYSTEINE; AMIODARONE; AZATHIOPRINE; BOSENTAN; COLCHICINE; CYCLOPHOSPHAMIDE; DIAMORPHONE; ETANERCEPT; GAMMA INTERFERON; MORPHINE; OPIATE; PENICILLAMINE; PIRFENIDONE; PREDNISONE; SILDENAFIL; UNCLASSIFIED DRUG;

ASSISTED VENTILATION; COMORBIDITY; CORRELATION COEFFICIENT; DISEASE SEVERITY; DRUG EFFICACY; DYSPNEA; FIBROSING ALVEOLITIS; FUNCTIONAL STATUS; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG DISEASE; MEDICAL LITERATURE; OXYGEN THERAPY; PATIENT SELECTION; POSITIVE END EXPIRATORY PRESSURE; PULMONARY REHABILITATION; QUALITY OF LIFE; RESPIRATION DEPRESSION; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

DYSPNEA; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MEDLINE; TRIIODOTHYRONINE;

EID: 84859217034     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2011.04.026     Document Type: Review

References (58)

1. G. Raghu, D. Weycker, J. Edelsberg, W.Z. Bradford, and G. Oster Incidence and prevalence of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 174 2006 810 816 (Pubitemid 44511663)
2. J.A. Bjoraker, J.H. Ryu, and M.K. Edwin Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 157 1998 199 203 (Pubitemid 28071283)
3. R. Hubbard, I. Johnston, and J. Britton Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study Chest 113 1998 396 400 (Pubitemid 28110017)
4. J.J. Swigris, W.G. Kuschner, S.S. Jacobs, S.R. Wilson, and M.K. Gould Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review Thorax 60 2005 588 594 (Pubitemid 40966214)
5. T.E. King Jr., M.I. Schwarz, and K. Brown Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality Am J Respir Crit Care Med 164 2001 1025 1032 (Pubitemid 32971653)
6. M. Demedts, J. Behr, and R. Buhl High-dose acetylcysteine in idiopathic pulmonary fibrosis N Engl J Med 353 2005 2229 2242 (Pubitemid 41697286)
7. H. Taniguchi, M. Ebina, and Y. Kondoh Pirfenidone in idiopathic pulmonary fibrosis Eur Respir J 35 2010 821 829
8. C.J. Ryerson, H.R. Collard, and S.Z. Pantilat Management of dyspnea in interstitial lung disease Curr Opin Support Palliat Care 4 2010 69 75
9. American Thoracic Society Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) Am J Respir Crit Care Med 161 2 Pt 1 2000 646 664
10. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 Am J Respir Crit Care Med 165 2002 277 304
11. Higgins JPT, Green Se. Cochrane handbook for systematic reviews of interventions version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org. Accessed March 15, 2011.
12. H.J. Schunemann, R. Jaeschke, and D.J. Cook An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations Am J Respir Crit Care Med 174 2006 605 614 (Pubitemid 44330555)
13. A. Azuma, T. Nukiwa, and E. Tsuboi Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 171 2005 1040 1047 (Pubitemid 40616955)
14. E. Fiorucci, G. Lucantoni, and G. Paone Colchicine, cyclophosphamide and prednisone in the treatment of mild-moderate idiopathic pulmonary fibrosis: comparison of three currently available therapeutic regimens Eur Rev Med Pharmacol Sci 12 2008 105 111 (Pubitemid 351833266)
15. T.E. King Jr., J. Behr, and K.K. Brown BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 177 2008 75 81
16. T.E. King Jr., C. Albera, and W.Z. Bradford Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial Lancet 374 2009 222 228
17. G. Raghu, K.K. Brown, and W.Z. Bradford A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis N Engl J Med 350 2004 125 133 (Pubitemid 38056223)
18. G. Raghu, K.K. Brown, and U. Costabel Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial Am J Respir Crit Care Med 178 2008 948 955
19. M. Selman, G. Carrillo, and J. Salas Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial Chest 114 1998 507 512 (Pubitemid 28387531)
20. H.R. Collard, K.J. Anstrom, M.I. Schwarz, and D.A. Zisman Sildenafil improves walk distance in idiopathic pulmonary fibrosis Chest 131 2007 897 899 (Pubitemid 46446887)
21. R.M. Jackson, M.K. Glassberg, and C.F. Ramos Sildenafil therapy and exercise tolerance in idiopathic pulmonary fibrosis Lung 188 2010 115 123
22. Idiopathic Pulmonary Fibrosis Clinical Research Network, D.A. Zisman, M. Schwarz, and K.J. Anstrom A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis N Engl J Med 363 2010 620 628
23. E.V. Moderno, W.P. Yamaguti, and G.P. Schettino Effects of proportional assisted ventilation on exercise performance in idiopathic pulmonary fibrosis patients Respir Med 104 2010 134 141
24. O. Nishiyama, Y. Kondoh, and T. Kimura Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis Respirology 13 2008 394 399 (Pubitemid 351503129)
25. S. Ozalevli, H. Karaali, D. Ilgin, and E.S. Ucan Effect of home-based pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis Multidisciplinary Respir Med 5 2010 31 37
26. Z. Daniil, P. Kitsanta, and G. Kapotsis CD8 + T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis Respir Res 6 2005 81
27. Z.D. Daniil, E. Papageorgiou, and A. Koutsokera Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis Pulm Pharmacol Ther 21 2008 26 31
28. J. De Vries, B.L. Kessels, and M. Drent Quality of life of idiopathic pulmonary fibrosis patients Eur Respir J 17 2001 954 961 (Pubitemid 32600345)
29. S. Glaser, O. Noga, and B. Koch Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis Respir Med 103 2009 317 324
30. E.D. Manali, P. Lyberopoulos, and C. Triantafillidou MRC chronic dyspnea scale: relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study BMC Pulm Med 10 2010 32
31. M. Mura, A. Ferretti, and O. Ferro Functional predictors of exertional dyspnea, 6-min walking distance and HRCT fibrosis score in idiopathic pulmonary fibrosis Respiration 73 2006 495 502
32. M. Mura, M. Zompatori, and A.M. Pacilli The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis Respir Care 51 2006 257 265 (Pubitemid 46888402)
33. O. Nishiyama, H. Taniguchi, and Y. Kondoh Quadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosis Chest 127 2005 2028 2033
34. O. Nishiyama, H. Taniguchi, and Y. Kondoh Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD Respir Med 101 2007 833 838
35. S.A. Papiris, Z.D. Daniil, and K. Malagari The Medical Research Council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis Respir Med 99 2005 755 761 (Pubitemid 40631303)
36. S.A. Papiris, A. Kollintza, and M. Karatza CD8 + T lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis J Inflamm (Lond) 4 2007 14
37. N. Tzanakis, M. Samiou, and I. Lambiri Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests Eur J Intern Med 16 2005 105 112 (Pubitemid 40523053)
38. C.S. Zimmermann, C.R. Carvalho, and K.R. Silveira Comparison of two questionnaires which measure the health-related quality of life of idiopathic pulmonary fibrosis patients Braz J Med Biol Res 40 2007 179 187 (Pubitemid 46237850)
39. T.Y. Martinez, C.A. Pereira, and M.L. dos Santos Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis Chest 117 2000 1627 1632 (Pubitemid 30413355)
40. R. Meliconi, G. Senaldi, and C. Sturani Complement activation products in idiopathic pulmonary fibrosis: relevance of fragment Ba to disease severity Clin Immunol Immunopathol 57 1990 64 73 (Pubitemid 20293066)
41. L.C. Watters, T.E. King, and M.I. Schwarz A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis Am Rev Respir Dis 133 1986 97 103 (Pubitemid 16189105)
42. A. Ferreira, C. Garvey, and G.L. Connors Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response Chest 135 2009 442 447
43. G. Ferreira, M. Feuerman, and P. Spiegler Results of an 8-week, outpatient pulmonary rehabilitation program on patients with and without chronic obstructive pulmonary disease J Cardiopulm Rehabil 26 2006 54 60 (Pubitemid 44474317)
44. B. Salhi, T. Troosters, M. Behaegel, G. Joos, and E. Derom Effects of pulmonary rehabilitation in patients with restrictive lung diseases Chest 137 2010 273 279
45. A.E. Holland, C.J. Hill, M. Conron, P. Munro, and C.F. McDonald Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease Thorax 63 2008 549 554 (Pubitemid 351831168)
46. D. Jastrzebski, A. Gumola, R. Gawlik, and J. Kozielski Dyspnea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation J Physiol Pharmacol 57 Suppl 4 2006 139 148 (Pubitemid 44638195)
47. N.A. Naji, M.C. Connor, S.C. Donnelly, and T.J. McDonnell Effectiveness of pulmonary rehabilitation in restrictive lung disease J Cardiopulm Rehabil 26 2006 237 243 (Pubitemid 44616970)
48. B. Rammaert, S. Leroy, B. Cavestri, B. Wallaert, and J.M. Grosbois [Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis] Rev Mal Respir 26 2009 275 282
49. D. Jastrzebski, J. Kozielski, and A. Zebrowska [Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis with inspiratory muscle training] Pneumonol Alergol Pol 76 2008 131 141
50. K.H. Choe, Y.J. Park, W.K. Cho, and C.M. Lim The effect of pulmonary rehabilitation in patients with chronic lung disease Tuberc Respir Dis 43 1996 736 745 (Pubitemid 27022434)
51. A. Holland, and C. Hill Physical training for interstitial lung disease Cochrane Database Syst Rev 4 2008 CD006322
52. C.R. Swinburn, H. Mould, T.N. Stone, P.A. Corris, and G.J. Gibson Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease Am Rev Respir Dis 143 5 Pt 1 1991 913 915
53. A.O. Harris-Eze, G. Sridhar, and R.E. Clemens Low-dose nebulized morphine does not improve exercise in interstitial lung disease Am J Respir Crit Care Med 152 6 Pt 1 1995 1940 1945
54. S. Allen, S. Raut, J. Woollard, and M. Vassallo Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis Palliat Med 19 2005 128 130 (Pubitemid 40443695)
55. A.F. Shorr, J.L. Wainright, C.S. Cors, C.J. Lettieri, and S.D. Nathan Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant Eur Respir J 30 2007 715 721 (Pubitemid 351194832)
56. C.J. Lettieri, S.D. Nathan, S.D. Barnett, S. Ahmad, and A.F. Shorr Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis Chest 129 2006 746 752
57. H.F. Nadrous, P.A. Pellikka, and M.J. Krowka Pulmonary hypertension in patients with idiopathic pulmonary fibrosis Chest 128 2005 2393 2399 (Pubitemid 41507585)
58. R.B. Hubbard, C. Smith, I. Le Jeune, J. Gribbin, and A.W. Fogarty The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study Am J Respir Crit Care Med 178 2008 1257 1261